Loading NARMADA price...
Peers are the listed companies in the exchange's own industry group: Animal Feed. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
Latest quarterIn the quarter to June 2026 (results filed 14 Aug 2026), sales rose 100.9% from a year earlier to Rs 22.3 cr and profit fell 26.0% to Rs 0.8 cr.
- Return on equity stayed under 10% from FY24 to FY26 (highest 7.3%).
- Operations used cash in FY26 (-Rs 1.3 cr) while reported profit was Rs 3.9 cr.
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
Over the last 15 results, the share rose on 7 and fell on 8, and moved by 3% or more on 5.
Q1 FY27: results filed 14 Aug 2026. The share went from its close on 13 Aug 2026 to its close on 17 Aug 2026 -2.36%.
Of every Rs 100 of sales in FY26, Rs 94 went on running costs, Rs 0.3 on depreciation, Rs 1.0 on interest and Rs 1.7 on tax; Rs 5.0 was left as profit.
Thin bar: money in (sales plus other income). Thick bar: where it went. Each year is scaled to its own sales, so the bars compare shares, not size.
Per year, compounded, between financial years FY26 and the year named; only spans our filings cover. The faint bar is the latest quarter against the same quarter a year earlier. Earnings per share is not shown: filed figures are not adjusted for bonus issues and splits, so its growth would mislead.
| Measure | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Sales growthSales against the previous financial year. | - | - | 30.6% | 19.3% |
| Operating marginProfit from operations, before depreciation, interest and tax, per Rs 100 of sales. | - | 5.2% | 8.4% | 6.2% |
| Net marginProfit after everything, per Rs 100 of sales. | - | 2.0% | 6.2% | 5.0% |
| ROEProfit as a percentage of shareholders' money (from the March balance sheet). | - | 6.0% | 7.3% | 6.5% |
| ROCEOperating profit as a percentage of all long-term capital, owners' and lenders'. | 10.7% | 13.6% | 10.5% | 10.0% |
| Debt to equityBorrowings divided by shareholders' money. Lower is safer. | 0.63x | 0.57x | 0.17x | 0.17x |
| Interest coverHow many times operating profit covers the interest bill. Higher is safer. | - | 2.4x | 7.5x | 7.5x |
Each row is coloured against this company's own usual level, not against other companies: green is better than its middle year, red worse, plain is close to it. ROE, ROCE and debt rows start once the filings carry a full balance sheet (FY22 at the earliest).
At FY26 it owned Rs 72 Cr of assets. Its owners funded 82% of that and borrowings 14%.
From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.
In FY26 the business itself brought in Rs -1 Cr, spent Rs 0 Cr on plant and equipment, and cash fell by Rs 4 Cr over the year.
Rs 100 or more means every rupee of reported profit arrived as cash.
Full financial year to 2026-03-31, from the company's cash flow statement.
Median rather than average, so one loss-making or one very expensive peer cannot drag the reference. Valuation is shown without a colour verdict: a higher multiple can mean expensive, or faster growth expected, and only you can decide which.
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| GODREJAGRO Godrej Agrovet Limited | 11,795 cr | 26.4x | 5.8x | 19.6% | 21.9% | 0.68 | 4.0% | +9.2% | 1.79% |
| AVANTIFEED Avanti Feeds Limited | 9,114 cr | 17.2x | 2.8x | 15.8% | 23.5% | 0.00 | 9.2% | +18.3% | 1.37% |
| AJOONI Ajooni Biotech Limited | 49 cr | 12.0x | 0.5x | 4.4% | 7.0% | 0.19 | 1.8% | +103.1% | 0.00% |
| NARMADA Narmada Agrobase Limited | 42 cr | 11.8x | 0.7x | 6.1% | 10.0% | 0.17 | 4.0% | +100.9% | 0.00% |
| MUKKA Mukka Proteins Limited | 2 cr | 10.7x | 0.0x | 14.0% | 22.1% | 1.45 | 4.2% | +186.7% | 0.00% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Operating margin has gone from 5.2% to 6.2% over these years - the share of every rupee of sales kept after running costs, before interest and tax. Full financial years only, so a part-year is never shown as a whole one. Hover any year for its complete figures.
2019 paid Rs 0.03 per share, about Rs 268 on Rs 1 lakh at today's price. Earlier years are restated to today's share count, so a bonus or split never reads as a dividend cut. Dividends are at the company's discretion and can be cut or skipped.
| Date | Party | Side | Qty | Price | Value |
|---|---|---|---|---|---|
| 2026-08-25 | MSB E TRADE SECURITIES LIMITED | BUY | 5,18,763 | 14.6 | Rs 0.76 Cr |
| 2026-08-25 | MSB E TRADE SECURITIES LIMITED | SELL | 5,18,751 | 14.19 | Rs 0.74 Cr |
| 2026-08-21 | SILLENIUM INFRA PROJECT PRIVATE LIMITED | SELL | 4,19,434 | 13.72 | Rs 0.58 Cr |
| 2026-08-06 | QE SECURITIES LLP | BUY | 4,00,088 | 14.26 | Rs 0.57 Cr |
| 2026-08-06 | QE SECURITIES LLP | SELL | 3,97,475 | 14.03 | Rs 0.56 Cr |
| 2026-08-05 | VAIBHAV RAJENDRA DOSHI | SELL | 9,18,495 | 15.53 | Rs 1.43 Cr |
| 2026-08-05 | VAIBHAV RAJENDRA DOSHI | BUY | 9,18,495 | 15.68 | Rs 1.44 Cr |
| 2026-08-05 | QE SECURITIES LLP | BUY | 4,60,270 | 15.78 | Rs 0.73 Cr |
The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Insider trading data unavailable.
Announcements unavailable.
Backtest an equity strategy on real market data, free - no card needed.
Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.